Allied Corp. announced that it has signed a joint venture agreement with Blueberries Medical Corp. to produce psychoactive and non-psychoactive derivatives.

By combining Allied's expertise in producing premium quality flower with Blueberries' leading extraction facilities, the companies will join forces in sales effort, while optimizing production capabilities. In addition to offering large volumes of cannabis flower from Colombia, Allied will now be enabled to offer high-quality derivative-based products within markets it currently distributes and expand its global presence. Allied's and Blueberries clients and supply channel partners span five (5) world continents that include Australia, Europe, Asia, South America and North America.

Allied's relationships with international partners are based on sustainable, long-term agreements that were designed with the Allied Inside™ supply chain in mind.